As of Friday close, Elevance Health Inc.’s (NYSE:ELV) stock was up $3.4, moving up 0.74 percent to $462.78. The average number of shares traded per day over the past five days has been 775,800 shares. 1 time new highs have been achieved over the past 5 days, with a -$11.28 fall in that time frame. In the last twenty days, the average volume was 898,880, while in the previous 50 days, it was 1,374,128.
Since last month, ELV stock retreated -2.73%. Shares of the company fell to $456.49 on 08/08/23, the lowest level in the past month. A 52-week high of $549.52 was reached on 01/03/23 after having rallying from a 52-week low of $412.00. Since the beginning of this year, ELV’s stock price has dropped by -9.78% or -$50.19, and marked a new high 1 time. However, the stock has declined by -15.78% since its 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
ELV stock investors should be aware that Elevance Health Inc. (ELV) stock had its last reported insider trading activity 29 days ago on Jul 21. Dixon Robert L JR, the Director of the company, disposed of 310 shares for $476.71 on Jul 21. It resulted in a $147,780 divestment by the insider. MCCARTHY GLORIA M sold 15,098 shares at an average price of $444.76 on Mar 24. The insider now owns 51,435 shares following the transaction. On Mar 09, EVP & President, Commercial Kendrick Charles Morgan JR sold 2,314 shares at $462.22 apiece. The transaction was valued at $1,069,577.
Valuation Metrics
Right now, Elevance Health Inc. (ELV) has a P/E ratio of about 17.33. The stock’s beta is 0.83. Besides these, the trailing price-to-sales (P/S) ratio of 0.65, the price-to-book (PB) ratio of 2.87, and the price-to-cash flow ratio of 10.14 may also be considered.
The latest dividend of $1.48 per share was paid out, remained unchanged from last year’s $1.48.
Financial Health
According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.65, and the total debt-to-equity ratio was 0.66. In the year ended June 29, operating margins totaled 5.60%. Based on annual data, ELV earned $27.07 billion in gross profit and brought in $156.59 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 11.40%. Return on equity (ROE) for the past 12 months was 17.30%.
In Elevance Health Inc.’s quarter-end financial report for June 29, it reported total debt of $24.86 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. ELV’s revenue rose 11.54% to $42.17 billion during the quarter, while net income inched up to $43.67 billion. While analysts expected Elevance Health Inc. to report $8.8 quarterly earnings, the actual figure was $9.04 per share, beating the consensus estimate by 2.70%. During the quarter, the company generated $3.13 billion in EBITDA. The liabilities of Elevance Health Inc. were 70.86 billion at the end of its most recent quarter ended June 29, and its total debt was $26.02 billion. The value of shareholders’ equity is $235.65 million.
Technical Picture
This quick technical analysis looks at Elevance Health Inc.’s (ELV) price momentum. With a historical volatility rate of 17.26%, the RSI 9-day stood at 47.61% on 18 August.
With respect to its five-day moving average, the current Elevance Health Inc. price is down by -2.38% percent or -$11.28. At present, ELV shares trade -2.76% below its 20-day simple moving average and -0.26% percent below its 100-day simple moving average. However, the stock is currently trading approximately +0.58% above its SMA50 and -15.36% below its SMA200.
Stochastic coefficient K was 28.19% and Stochastic coefficient D was 39.03%, while ATR was 8.35. Given the Stochastic reading of 29.82% for the 14-day period, the RSI (14) reading has been calculated as 50.18%. As of today, the MACD Oscillator reading stands at -3.09, while the 14-day reading stands at -4.09.
Analyst Ratings
Elevance Health Inc. downgraded its rating on Elevance Health Inc. (NYSE: ELV) to a Peer perform in a note to investors on July 12, 2023. The analysts firm previously had an Outperform rating on the stock.Elevance Health Inc. (ELV) has been rated Buy by analysts. According to 0 brokerage firms, ELV is a sell, and 4 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 2 analysts rate Elevance Health Inc. stock as buy, with 16 recommending it as overweight.
With a median target price of $572.00, the current consensus forecast for the stock is $493.00 – $629.00. Based on these forecasts, analysts predict Elevance Health Inc. (ELV) will achieve an average price target of $570.95.
